ONLINE REGISTRATION FORM
Welcome to the registration web site for Shades of Grey: Key Questions in the Future of Interferon Therapy for Hepatitis C To reserve your place for this activity, please complete the following information.
Monday, November 3, 2008
6:30–9:30 PM
San Francisco Marriott
Yerba Buena Ballroom, Salons 9-15, 3rd Floor
55 Fourth Street, San Francisco, CA 94103
Program Agenda
SHADES OF GREY: KEY QUESTIONS IN THE FUTURE OF INTERFERON THERAPY FOR HEPATITIS C
| 6:30-7:15 PM |
Registration |
| 7:15-7:20 PM |
Introduction
Ira M. Jacobson, MD |
| 7:20-7:25 PM |
ARS Questions |
| 7:25-7:50 PM |
Peginterferon and Ribavirin: Do Dosing and Formulation Really Make a Difference?
Bruce R. Bacon, MD |
| 7:50-7:55 PM |
ARS Questions |
| 7:55-8:20 PM |
Novel Interferon Formulations: A Potential Advance or a Lateral Move?
David R. Nelson, MD |
| 8:20-8:25 PM |
ARS Questions |
| 8:25-8:50 PM |
Recent Developments in Specifically Targeted Small Molecule HCV Therapies: Will Interferons Remain Indispensable?
Nezam Afdhal, MD |
| 8:50-8:55 PM |
ARS Questions |
| 8:55-9:15 PM |
The Challenges of Immunomodulatory Therapy in HCV: Should we Keep Trying?
John McHutchinson, MD |
| 9:15-9:30 PM |
Audience Q&A |
Presented for attendees of the 59th AASLD Annual Meeting (or The Liver Meeting®). This event/function is sponsored by the Institute for Continuing Healthcare Education and supported by Novartis Pharmaceuticals Corporation and Human Genome Sciences, Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.
You will receive an electronic CONFIRMATION of your registration within 48 hours of receipt.
*These fields are required in order to complete your registration.
|
|